Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal E Dunlap

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Oral Oncology|March 30, 2017
High-dose versus weekly cisplatin definitive chemoradiotherapy for HPV-related oropharyngeal squamous cell carcinoma of the head and neckCesar Augusto Perez, Xiaoyong Wu, Mark J Amsbaugh, et al.
Head & Neck|January 23, 2026
Short-Term Outcomes of Advanced Pneumatic Compression Device Versus Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical TrialBarbara A Murphy, Derek K Smith, Cristina M Kline-Quiroz, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Genome-Wide Variations of End Motif in Cell-Free DNA Fragments Distinguish Immunotherapy Responders from Non-Responders in Head and Neck Cancer: A Multi-Institute Prospective StudyRavi Bandaru, Hailu Fu, Haizi Zheng, et al.
The Journal of Clinical Investigation|May 19, 2026
Genome-wide variation in cell-free DNA end motif entropy predicts immunotherapy response in head and neck cancerRavi Bandaru, Hailu Fu, Haizi Zheng, et al.
Oral Oncology|March 9, 2019
A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neckMatthew C Ward, Nancy Y Lee, Jimmy J Caudell, et al.
Eclinicalmedicine|October 23, 2025
Avasopasem manganese treatment for severe oral mucositis from chemoradiotherapy for locally advanced head and neck cancer: phase 3 randomized controlled trial (ROMAN)Carryn Anderson, Christopher M Lee, Joseph Randall Kelley, et al.
Oral Oncology|February 20, 2022
Influence of Treatment Package Time on outcomes in High-Risk Oral Cavity Carcinoma in patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Oral Cavity Collaborative studyAhmed I Ghanem, Neil M Woody, Mathew A Schymick, et al.
Cancer Research Communications|March 6, 2026
The KRAS-variant and cetuximab in HPV-positive oropharyngeal cancer - results from the NRG/RTOG 1016 trialJoanne B Weidhaas, Jonathan Harris, Maura L Gillison, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2017
Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937Elizabeth M Gore, Chen Hu, Alexander Y Sun, et al.
Current Oncology (Toronto, Ont.)|July 2, 2021
Outcomes of Post-Operative Treatment with Concurrent Chemoradiotherapy (CRT) in High-Risk Resected Oral Cavity Squamous Cell Carcinoma (OCSCC): A Multi-Institutional CollaborationArslan Babar, Neil M Woody, Ahmed I Ghanem, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Oral Oncology|March 30, 2017
High-dose versus weekly cisplatin definitive chemoradiotherapy for HPV-related oropharyngeal squamous cell carcinoma of the head and neckCesar Augusto Perez, Xiaoyong Wu, Mark J Amsbaugh, et al.
Head & Neck|January 23, 2026
Short-Term Outcomes of Advanced Pneumatic Compression Device Versus Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical TrialBarbara A Murphy, Derek K Smith, Cristina M Kline-Quiroz, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Genome-Wide Variations of End Motif in Cell-Free DNA Fragments Distinguish Immunotherapy Responders from Non-Responders in Head and Neck Cancer: A Multi-Institute Prospective StudyRavi Bandaru, Hailu Fu, Haizi Zheng, et al.
The Journal of Clinical Investigation|May 19, 2026
Genome-wide variation in cell-free DNA end motif entropy predicts immunotherapy response in head and neck cancerRavi Bandaru, Hailu Fu, Haizi Zheng, et al.
Oral Oncology|March 9, 2019
A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neckMatthew C Ward, Nancy Y Lee, Jimmy J Caudell, et al.
Eclinicalmedicine|October 23, 2025
Avasopasem manganese treatment for severe oral mucositis from chemoradiotherapy for locally advanced head and neck cancer: phase 3 randomized controlled trial (ROMAN)Carryn Anderson, Christopher M Lee, Joseph Randall Kelley, et al.
Oral Oncology|February 20, 2022
Influence of Treatment Package Time on outcomes in High-Risk Oral Cavity Carcinoma in patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Oral Cavity Collaborative studyAhmed I Ghanem, Neil M Woody, Mathew A Schymick, et al.
Cancer Research Communications|March 6, 2026
The KRAS-variant and cetuximab in HPV-positive oropharyngeal cancer - results from the NRG/RTOG 1016 trialJoanne B Weidhaas, Jonathan Harris, Maura L Gillison, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2017
Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937Elizabeth M Gore, Chen Hu, Alexander Y Sun, et al.
Current Oncology (Toronto, Ont.)|July 2, 2021
Outcomes of Post-Operative Treatment with Concurrent Chemoradiotherapy (CRT) in High-Risk Resected Oral Cavity Squamous Cell Carcinoma (OCSCC): A Multi-Institutional CollaborationArslan Babar, Neil M Woody, Ahmed I Ghanem, et al.
Pageof 6